The Benefits of Testosterone Therapy: What Clinical Evidence Actually Shows
In men with confirmed hypogonadism, the strongest evidence for testosterone therapy is improved sexual desire and function. It can also increase bone density and lean mass, reduce fat mass, and modestly improve mood. Evidence for energy and cognitive benefits is weaker. Every benefit applies within one frame: restoring testosterone to a normal physiological range, not exceeding it. Qualification requires both symptoms and laboratory confirmation.
You recognize the pattern. You're sleeping enough, but the energy isn't there. You're training, but your body composition keeps shifting in the wrong direction. Your mood is flat in a way that's hard to name, not depression exactly, but not right either. Libido is down. Mental sharpness feels inconsistent. None of it is dramatic enough to explain in a single sentence, but the cumulative picture is hard to ignore.
The testosterone therapy benefits conversation you'll find online tends toward two unhelpful extremes. One version promises transformation (harder body, sharper mind, restored drive, renewed confidence) with language that reads more like advertising than medicine. The other dismisses TRT as unnecessary, overprescribed, and risky, usually without engaging the evidence seriously. Neither version helps you make a good decision.
This post documents what the clinical evidence actually supports, defines who qualifies based on current medical standards, and clarifies, plainly, what testosterone therapy does and does not do. It reflects how testosterone therapy is approached at Body Balance Medical in Las Vegas.
One frame governs everything that follows: testosterone replacement therapy, when medically indicated, is about returning levels to a clinically appropriate physiological range. Not exceeding it.
What Testosterone Actually Does in the Body
Testosterone is not a single-purpose hormone. It participates in energy metabolism, muscle protein synthesis, bone mineral density maintenance, red blood cell production, cognitive function, and sexual health signaling. When levels fall below the normal physiological range, each of those systems is affected in measurable ways.
That decline has a clinical name: hypogonadism. It's a diagnosable condition with documented consequences, not simply the expected result of getting older. Men can experience primary hypogonadism, originating in the testes, or secondary hypogonadism, driven by disrupted signaling from the hypothalamic-pituitary axis. The distinction matters for both diagnosis and treatment.
There are two very different ways testosterone can be administered to men. The first is medically supervised replacement therapy, which aims to restore levels to a normal physiological range in men with confirmed hypogonadism. The second is supraphysiologic dosing: using exogenous testosterone to push levels above that range for athletic or aesthetic purposes.
The two categories are not the same. This post is only about one of them.
The Clinically Supported Benefits of TRT for Men
Every benefit discussed in this section reflects what the evidence supports for medically appropriate restoration: returning testosterone to a normal range in men with confirmed deficiency. These are not outcomes you should expect unconditionally, and they are not performance-enhancement claims.
Energy
Low testosterone is one of several possible causes of fatigue. Testosterone influences red blood cell production and metabolism, and hypogonadism is associated with reduced lean mass and the metabolic changes that follow.
The evidence on energy is mixed. Some men report less fatigue once testosterone is restored to a normal range, but the large Testosterone Trials in older men did not find a significant improvement in fatigue. Sleep quality, thyroid function, and broader metabolic health all play roles, and TRT addresses the hormonal component only.
If your fatigue has a hormonal component, that component is addressable, but it requires a complete picture, not a single data point.
Understanding when and what to test is part of that complete picture. Low testosterone treatment benefits in the energy domain are real, but they apply specifically to men whose fatigue has a measurable hormonal basis.
Mood
Testosterone plays a role in dopamine regulation, and dopamine is closely tied to motivation, mood stability, and the sense of mental engagement that men often describe losing before they can fully articulate why. Men with confirmed hypogonadism frequently report irritability, low motivation, diminished mental sharpness, and a kind of emotional flatness that doesn't respond to the interventions that used to help.
Some men see modest improvement in mood with appropriate testosterone replacement. Studies have not shown that testosterone improves memory or other cognitive function. Neither is a guarantee.
Mood symptoms in men 35–60 are multifactorial. When low testosterone is a contributing cause, addressing it is clinically appropriate. When it isn't (when testosterone levels are normal and mood symptoms persist), TRT will not fix them. The benefits of TRT for men in this domain are real, but they apply to the hormonal component of mood, not every cause of it. If mood changes are a significant part of what you're experiencing, there's more to that evaluation than a single hormone panel.
Libido and Sexual Function
Testosterone is the primary biological driver of libido in men. Low levels correlate consistently with reduced sexual interest and, in many men, reduced function. This is one of the more direct connections in the hypogonadism literature, and it's often one of the first symptoms men notice.
Restoration of testosterone to a normal range addresses the hormonal dimension of sexual function. Erectile dysfunction has multiple contributing causes (vascular, neurological, and hormonal), and TRT may not fully resolve function when non-hormonal factors are also present. Testosterone is not FDA-approved to treat erectile dysfunction. A thorough evaluation helps identify whether testosterone is a meaningful contributor to what you're experiencing, or whether other causes deserve primary attention.
Body Composition
Testosterone drives muscle protein synthesis. In hypogonadal men, the absence of adequate testosterone signaling is associated with loss of lean mass and accumulation of adipose tissue, particularly visceral fat, the kind that concentrates around the midsection and carries the greatest metabolic consequences.
In men with confirmed hypogonadism, TRT is associated with improvements in lean body mass and reductions in fat mass. These outcomes reflect restored hormone signaling, not performance enhancement, and they depend on physical activity: testosterone works alongside exercise, not instead of it.
TRT is not a standalone weight-loss treatment. Testosterone replacement therapy benefits for body composition are meaningful for hypogonadal men, but they operate within the physiological effects of restored signaling. For men who have both low testosterone and significant weight goals, Body Balance Medical's Balance Rate program coordinates TRT and GLP-1 therapy under one clinical team.
Bone Density
This may be the least-discussed benefit of testosterone replacement, but it is clinically significant over time. Testosterone contributes to bone mineral density maintenance in men. Hypogonadism is associated with accelerated bone loss and a meaningful increase in fracture risk, particularly as men move through their 50s and beyond.
TRT in hypogonadal men can increase bone density, although a 2024 analysis of the TRAVERSE trial found that it did not reduce fractures. There's no subjective experience of denser bone, which is why it often gets crowded out by conversations about energy and libido, but for men making a long-term clinical decision, it belongs in the picture.
The 2025 FDA Labeling Change: What Changed and Why It Matters
In February 2025, the FDA removed the cardiovascular language from the boxed warning on testosterone products and added a class-wide warning about increased blood pressure. It's worth understanding what that change means, and what it doesn't.
The prior warning existed because earlier, smaller studies raised concerns about a possible association between testosterone therapy and cardiovascular events. Those studies generated legitimate questions, but they were not designed with the scale or rigor to answer them definitively.
The TRAVERSE trial was a large, prospective, randomized controlled trial that evaluated cardiovascular outcomes in hypogonadal men receiving testosterone replacement. It found testosterone noninferior to placebo for major adverse cardiac events: heart attacks, strokes, and cardiovascular deaths occurred at similar rates. It also found higher rates of atrial fibrillation, pulmonary embolism, and acute kidney injury in the testosterone group. Full results are published in the New England Journal of Medicine at Lincoff et al., NEJM, 2023.
The safety conversation has shifted. It has not disappeared.
What this means for the reader: the cardiovascular question is better understood than it was. This is relevant if you've encountered that concern as a reason not to consider evaluation.
What it does not mean: that TRT is appropriate for every man, or that cardiovascular evaluation before initiating treatment is unnecessary. The TRAVERSE findings support responsible prescribing, not unmonitored use.
Who Qualifies for Testosterone Therapy
The clinical standard is clear: qualification requires both symptomatic presentation and laboratory confirmation. Neither alone is sufficient for a responsible clinical decision.
Symptoms associated with hypogonadism include fatigue, reduced libido, mood changes, cognitive fog, decreased muscle mass, increased body fat, poor sleep, and reduced motivation. These symptoms are real, and they are also nonspecific. Each of them can have causes entirely unrelated to testosterone levels. A symptom picture alone is not a diagnosis.
Laboratory confirmation starts with total testosterone, but that's not the complete picture. A responsible evaluation also includes free testosterone, SHBG (sex hormone-binding globulin, the protein that binds testosterone and makes it unavailable for biological use), LH and FSH (which identify whether the problem originates in the testes or the hypothalamic-pituitary axis), hematocrit, PSA, and a complete metabolic panel.
Self-diagnosis is insufficient for a straightforward physiological reason. Testosterone levels fluctuate meaningfully based on time of day, recent stress, sleep quality, and acute illness. A single low result without clinical context can be misleading in both directions. The established clinical standard is morning draws, done fasting, on two separate occasions before a diagnosis is made. That's not bureaucratic caution; that's what produces a reliable result.
If the question is whether TRT is right for you, the evaluation process exists to answer it. Understanding when to test and what testing actually measures is the right starting point.
What the Evaluation at Body Balance Medical Looks Like
At Body Balance Medical, the evaluation with Teresa Hernandez, MSN FNP-BC, includes a comprehensive lab panel, full symptom review, health history, and clinical assessment of contraindications.
The evaluation is designed to produce a diagnosis, not a sale. Not every man who presents with these symptoms has clinically low testosterone. Not every man who has clinically low testosterone is an appropriate candidate for replacement therapy. The evaluation determines which category applies, and what the right clinical response is either way.
Honest Risks and Side Effects
Testosterone replacement therapy, when clinically indicated and properly managed, has a well-characterized risk profile. These risks are real. They are also manageable with appropriate oversight.
- Erythrocytosis (elevated red blood cell count)
The most common clinically significant side effect of TRT. When red blood cell production increases beyond normal range, blood viscosity rises and cardiovascular risk increases. Monitored through routine hematocrit testing, which is standard in ongoing TRT management.
- Testicular atrophy and fertility impact
Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal axis, which reduces the body's own testosterone production and decreases sperm output. Relevant for any man considering future fertility, a factor that a thorough clinical conversation should address before initiating treatment.
- Acne and skin changes
Common, particularly with topical delivery methods. Generally manageable and often resolves with delivery method adjustments.
- Sleep apnea exacerbation
TRT can worsen existing obstructive sleep apnea. Screening for sleep apnea before and during treatment is appropriate clinical practice.
- Prostate monitoring
PSA monitoring is standard throughout TRT. Testosterone replacement is contraindicated in men with known or suspected prostate cancer. The relationship between TRT and prostate health is more nuanced than old data suggested, but monitoring remains non-negotiable.
- Cardiovascular monitoring
Even after the 2025 labeling change, baseline and ongoing cardiovascular and blood pressure evaluation remains part of appropriate clinical practice.
The risks are real. So is the monitoring protocol designed to catch them early.
What TRT Doesn't Do
This section is not a disclaimer. It is a service to the reader.
In hypogonadal men, restoring testosterone levels is associated with improvements in body composition: more lean mass, less fat mass. That is not the same as primary treatment for obesity. Weight loss requires caloric deficit, physical activity, and in many cases additional clinical intervention.
When low testosterone is a contributing cause of mood symptoms, addressing it is appropriate. When it isn't, TRT will not solve the problem. If a man's testosterone levels are normal and he is experiencing depression or significant mood disruption, the clinical response is not testosterone therapy.
Medically supervised testosterone replacement aims to return levels to a normal physiological range. Supraphysiologic dosing for athletic performance or aesthetic outcomes is a categorically different use with a categorically different risk profile. That is not what this clinic provides or what this post describes.
Sleep quality, nutrition, physical activity, and metabolic health all affect how a man responds to treatment. Hormonal restoration is one component of a clinical picture, not a substitute for the health behaviors that make it work.
Testosterone therapy restores what should be there. It does not manufacture outcomes that weren't possible to begin with.
Ongoing Monitoring: What Happens After You Start
Initiating TRT is not a set-and-forget decision. Ongoing monitoring is what makes the treatment both safe and effective over time.
Follow-up labs are typically drawn at 6–8 weeks after initiating treatment, then every 3–6 months once levels have stabilized. Those labs include hematocrit, testosterone levels (total and free), PSA, and metabolic markers. Dose adjustments are common in the early months; the clinical goal is to land in a normal physiological range, and that takes calibration. Getting there quickly is less important than getting there correctly.
Delivery method affects the monitoring rhythm. Body Balance Medical offers Biote pellet therapy, a subcutaneous implant that releases testosterone gradually over several months, with a steadier pattern than weekly injections. Pellets are compounded and are not FDA-approved. More detail on delivery options is at types of testosterone replacement therapy and on pellet therapy specifically at Biote hormone pellet therapy in Las Vegas.
A provider who does not require follow-up labs is not providing appropriate care. The monitoring is not optional; it is what separates responsible prescribing from the alternative.
Testosterone Therapy at Body Balance Medical
Body Balance Medical is a LegitScript-certified medical clinic in Summerlin, Las Vegas. Teresa Hernandez, MSN FNP-BC, is Biote-certified and provides testosterone replacement therapy as part of a complete hormone evaluation, not as a prescription based on symptoms alone. Testosterone is started only after an in-person visit and lab work.
Every patient receives a full lab panel before any prescription is written. The clinical process is designed to produce an accurate diagnosis and an appropriate recommendation. Some men who come in with these symptoms will be candidates for TRT. Others won't, and the evaluation is designed to identify which is which, not to sell a predetermined outcome.
For men managing both hormonal and weight-related goals, the Balance Rate program lets you add compounded tirzepatide while your hormone membership is active.
More information on the clinical team is at our team page, and broader context on hormone evaluation is at hormone optimization.
Frequently Asked Questions
What are the clinically documented benefits of testosterone therapy?
In men with confirmed hypogonadism, the strongest evidence is for improved sexual desire and function. Testosterone can also increase bone density and lean mass, reduce fat mass, and modestly improve mood; evidence for energy and cognitive benefits is weaker. Every one of these is framed as restoration of normal physiological function: returning levels to an appropriate range, not exceeding it. Results vary by individual and depend on factors including sleep quality, metabolic health, and physical activity. For more context, see Body Balance Medical's TRT program overview.
Who qualifies for TRT, and who doesn't?
Qualification requires both symptoms consistent with hypogonadism and laboratory confirmation of low testosterone. Symptoms alone are not sufficient; they overlap with many other conditions. Lab results alone are not sufficient either, because testosterone levels fluctuate and a single low reading without clinical context can be misleading. Men with confirmed hypogonadism who have no medical contraindications are generally appropriate candidates. Men with normal testosterone levels, or with active prostate cancer, are not. The evaluation process determines which category applies.
How long does it take for TRT to work?
This varies by individual, delivery method, and which symptoms are being addressed. Changes in sexual desire are often among the first that men notice, while body composition changes take months and depend on physical activity. There is no universal timeline.
Is testosterone therapy safe for the heart after the 2025 FDA labeling change?
In February 2025, the FDA removed the cardiovascular language from the boxed warning on testosterone products and added a class-wide warning about increased blood pressure. The change followed the TRAVERSE trial, which found testosterone noninferior to placebo for major adverse cardiac events in men with hypogonadism, along with higher rates of atrial fibrillation, pulmonary embolism, and acute kidney injury. Appropriate candidate selection, baseline cardiovascular evaluation, and ongoing monitoring remain standard practice, and TRT is not appropriate for every man.
Does TRT cause weight loss?
No. TRT can improve body composition in hypogonadal men by restoring normal hormone signaling, which can increase lean mass and reduce fat mass, but it does not function as a primary treatment for obesity. Weight loss requires a caloric deficit, physical activity, and in many cases additional clinical support. For men with significant weight goals alongside hormonal concerns, coordinated care that includes GLP-1 therapy may be more appropriate than TRT alone.
What is the difference between TRT and testosterone supplementation?
Medically supervised TRT is a clinically indicated treatment for confirmed hypogonadism, prescribed by a licensed provider, dispensed through a licensed pharmacy, and managed with ongoing lab monitoring. It aims to restore testosterone to a normal physiological range. "Testosterone supplementation" in non-medical contexts often refers to over-the-counter products, online sources, or compounds labeled "research use only", none of which carry the prescriber oversight, pharmacy verification, or monitoring protocols that responsible TRT requires. The two are not equivalent in evidence, safety oversight, or legal standing.
What does ongoing monitoring for TRT involve?
Monitoring typically includes follow-up labs at 6–8 weeks after starting treatment, then every 3–6 months once stable. The panel covers testosterone levels, hematocrit, PSA, and metabolic markers. Dose adjustments are common early in treatment. For more on the evaluation and testing process, see When to Get Tested for Optimal Health.
Is TRT Right for You? Start With an Evaluation.
The only way to know whether testosterone therapy is appropriate is a proper evaluation: labs, symptoms, health history, and a conversation with a qualified provider. Not more research. Not self-treatment.
Apply for Your TRT AssessmentDisclaimer: The information in this article is for educational purposes only and is not a substitute for individual medical advice. FDA-approved testosterone products exist for men with low testosterone caused by specific medical conditions; they are not approved for low testosterone due to aging alone. Some testosterone products, including hormone pellets, are compounded. Compounded medications are not FDA-approved. The FDA does not review compounded medications for safety, effectiveness or quality. Whether TRT is appropriate for you is a decision to make with a licensed clinician based on your lab results, health history, and symptoms. Individual results vary and are not guaranteed.